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Dominik Geisel
the aim of this study was to evaluate the risk of pneumothorax and need for chest tube insertion 
in ct‑guided lung biopsies and identify predictors focusing on pulmonary emphysema determined 
with quantitative computed tomography. to that end, we retrospectively analysed the incidence 
of pneumothorax and chest tube insertion in 371 CT-guided lung biopsies with respect to the 
quantitative emphysema score determined with the density mask technique. other possible impact 
factors considered were lesion diameter, length of biopsy pathway within the lung parenchyma, 
lung lobe, needle size, puncture technique, patient positioning and interventionalist’s level of 
experience. Quantitative emphysema scores of the lung were significantly higher in patients who 
developed instant pneumothorax (27%, p < 0.0001), overall pneumothorax (38%, p = 0.001) and 
had chest tube insertion (9%, p = 0.006) compared to those who did not when analysed with the 
Mann–Whitney U‑test. in logistic regression analysis with inclusion of the other possible impact 
factors, the quantitative emphysema score remained a statistically significant predictor for all three 
output parameters. This was confirmed with least absolute shrinkage and selection operator (Lasso) 
regression analysis. in conclusion, quantitatively determined pulmonary emphysema is a positive 
predictor of the pneumothorax rate in ct‑guided lung biopsy and likelihood of chest tube insertion.
Incidentally detected pulmonary nodules often pose a diagnostic dilemma. In its 2017 guidelines, the Fleischner 
society recommends either positron emission tomography/computed tomography (PET/CT) or biopsy for an 
incidentally found singular, solid pulmonary nodule greater than 8 mm in diameter to rule out  malignancy1. 
Furthermore, in patients with more than one primary malignancy, the origin of pulmonary metastasis is not 
apparent from diagnostic imaging. In such a scenario, treatment planning also requires tissue sampling for 
pathologic clarification.
CT-guided biopsy of pulmonary nodules has become a standard procedure for tissue sampling. Compared to 
navigational bronchoscopy with biopsy, percutaneous CT-guided biopsies are less expensive and have a higher 
diagnostic yield in the assessment of peripheral pulmonary  nodules2,3. Compared to surgery, percutaneous CT-
guided lung biopsies are less invasive and reduce the amount of anaesthesia required. Nevertheless, CT-guided 
lung biopsies also come along with  risks4. In addition to the risks shared by all CT-guided interventions like 
infection, bleeding and nerve injury, lung biopsies have specific risks including pneumothorax and inadvertent 
creation of a fistula between a bronchus and blood vessel with possibly fatal gas  embolism5. Pneumothorax is by 
far the most frequent complication of lung biopsies.
In the literature, the frequency of pneumothorax associated with lung biopsy is reported to range from 9 to 
54%6, among them a large retrospective study of 9,783 lung biopsies with a rate of 35%4. The reported rate of 
patients requiring chest tube placement ranges from 2 to 15%6.
There are a number of studies investigating factors which might have an impact on the occurrence of pneu-
mothorax and the need for chest tube insertion following lung biopsy with pulmonary emphysema being one 
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of  them6–12. In these studies, pulmonary emphysema was assessed visually, which is rather subjective and time-
consuming as the lung is a large organ covering many slices in a CT scan.
Over the last decade, quantitative CT has emerged as an objective method to quantify emphysematous 
parenchymal changes by identifying pulmonary areas of low attenuation in thin-section chest CT scans with a 
suitable software algorithm. This so-called density mask technique is described in detail  elsewhere13. To date, 
there are only a few studies, each including only a moderate number of study patients, that have employed this 
quantitative method to analyse the associated risk of pneumothorax and while there is more evidence in favour 
of quantitative emphysema being a risk  factor14,15 there is also some against  it16.
The aim of this study was to elucidate the rate of pneumothorax in our department and to identify risk fac-
tors focusing on pulmonary emphysema as determined with quantitative CT. For that purpose, we assessed 
pulmonary emphysema on thin-section CT scans acquired within a year prior to the biopsy using a dedicated 
software package. In order to include all relevant risk factors besides pulmonary emphysema the pertinent lit-
erature was thoroughly reviewed prior to data acquisition. The identified risk factors which were included into 
the analysis comprised needle size, puncture technique, lesion size, length of puncture tract in lung parenchyma, 
lung lobe harbouring the lesion, positioning of the patient during the procedure and level of experience of the 
 interventionalist7,8,17,18.
Materials and methods
The study was approved by the institutional review board (Charité’s Ethics Committee—Charitéplatz 1, 10117 
Berlin, Germany) and all methods were carried out in accordance with relevant guidelines and regulations. The 
ethic committee waived informed consent requirements for this retrospective study.
Study design. We retrospectively analysed 371 CT-guided lung biopsies performed at our institution on 
the same CT scanner over a 10-year period from 2009 to 2018. A flow chart of patients included into the study 
is provided in Fig. 1. A thin-section chest CT scan acquired within a year prior to the biopsy was used to deter-
mine a quantitative pulmonary emphysema score with the density mask technique. Information on lung lesion 
diameter, length of biopsy pathway within the lung parenchyma measured from the pleural puncture site to the 
411 patients who received a lung 
biopsy in our institution during the 
time period from January 2009 to 
December 2018 by one of the 




without appropriate thin-section 
CT of the entire lung available
371 patients
14 patients
with failure of automatic airway 
identification in the quantitative 
emphysema analysis or 
incomplete documentation of 
relevant parameters
Figure 1.  Flow chart of patients included into the study. * Inclusion criteria for interventionalists were being 
a board-certified physician training to become a radiologist and having started the interventional career with 
CT-guided interventions during the stated time period. A random selection of interventionalists meeting these 
criteria was performed.
3Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:10978  | https://doi.org/10.1038/s41598-020-67348-0
www.nature.com/scientificreports/
edge of the pulmonary lesion along the needle path, lobe of lesion location and positioning of the patient during 
the procedure was retrieved from the dose reports and fluoroscopy images, both stored in the picture archiving 
and communication system (PACS). The needle size and puncture technique were retrieved from the written 
reports, and the number of lung biopsies previously performed by each interventionalist was determined from 
the radiological information system (RIS) and used as a surrogate for his or her level of experience.
Fluoroscopy images of the lung biopsy procedure and the x-ray of the lung routinely performed 4 h after 
biopsy as well as any additional lung images acquired during the following week were screened for pneumotho-
rax. If a pneumothorax was identified, follow-up images were further analysed to find out whether a chest tube 
was inserted to treat the pneumothorax or whether spontaneous resorption of the pneumothorax occurred. 
Findings were grouped into three categories: (1) “instant pneumothorax” for pneumothorax identified during 
the procedure, (2) “overall pneumothorax” for pneumothorax identified during the procedure or on follow-up 
images acquired within one week and (3) “chest tube insertion” for biopsy-related pneumothorax treated by 
chest tube insertion.
CT fluoroscopy and interventional workflow. All CT-guided lung biopsies were performed on the 
same CT scanner, a Siemens Definition AS with a 32-row detector and a z-flying focal spot. The so called quick-
check technique with intermittent 5-mm single-slice images taken was used. The quick-check technique is essen-
tially analogous to conventional CT except for faster reconstruction times and manual table positioning by the 
 radiologist19. The image acquisition parameters were set at 30 mAS and 120  kV unless the interventionalist 
deemed it necessary to alter these parameters. All biopsies investigated in this study were performed by radiolo-
gists who started their interventional career during the study period. This setting allowed us to count the lung 
biopsies performed by the interventionalist before the one in question and that number was used as a surrogate 
for his or her level of experience at the time of the study biopsy.
A conventional CT scan of the region of interest was obtained prior to the intervention and was used to plan 
the best way to access the lesion. Basic principles observed for pathway planning as best as possible were choos-
ing an angle perpendicular to the pleura, not crossing a lung fissure, avoiding large bronchi or blood vessels, 
minimising the length of the puncture pathway and passing at the upper edge of ribs in order to minimise the 
likelihood of costal nerve or vessel injury as recommended in the  literature20,21.
Routine preparation before the biopsy procedure included lead shielding and sterile covering, followed by 
administration of local anaesthesia.
In the majority of cases, a coaxial technique was employed using a coaxial needle (Co-axial Introducer Needle, 
Argon Medical Devices, Athens, TX 75751, USA) combined with a cutting needle (Quick-Core Biopsy Needle, 
Cook Medical, Bloomington, IN 47404, USA) and 2 samples, each 2 cm in length, were taken. In most cases, 
a 19 Gauge coaxial needle was combined with a 20 Gauge cutting needle. Less frequently, an 18- or 20-Gauge 
cutting needle was used alone, taking only one 2-cm sample. For our analysis, we retrieved the needle size and 
technique from the written reports.
emphysema score. Replacement of normal lung parenchyma with an attenuation of approx. -850 HU 
on inspiratory CT scans by air-filled spaces with lower attenuation is characteristic for emphysematous lung 
destruction. The density masque technique has emerged as an objective and quantitative method to determine 
the degree of pulmonary emphysema. Most commonly, a threshold of − 950 HU is used to separate emphyse-
matous from normal lung  parenchyma22,23. After automatic identification of the lung and airway segmentation 
voxels within the lung below − 950 HU are automatically identified for calculating the emphysema score. The 
emphysema score is defined as the number of voxels below − 950 HU divided by the total number of voxels of 
the lung. The quantitative emphysema score is therefore referred to as %LAA-950 (low-attenuation areas less 
than − 950 Hounsfield Units) from here onwards. Parameters of the CT scans used in this study for quantita-
tive emphysema analysis were as follows: 120 kV, automatic dose modulation (range 100–500 mA), standard 
kernel, ≤ 1.25 mm slice thickness and acquisition in inspiration. Several software packages are now available for 
this analysis; in this study, we used the software package from General Electrics (AW Server 3.2, Ext. 1.2, 2016).
Statistics. The Shapiro–Wilk test was used to test for normal distribution. The Mann–Whitney U-test was 
used as a nonparametric test to compare continuous variables between two groups. The Chi-square test was 
employed to compare categorical variables.
Binomial logistic regression analysis was used to identify factors with an impact on the likelihood of lung 
biopsy-related instant pneumothorax, overall pneumothorax and chest tube insertion. Additionally, least absolute 
shrinkage and selection operator (Lasso) regression with control variables to be selected by lassos and tenfold 
cross-validation was performed. Measures of performance to predict instant pneumothorax, overall pneumo-
thorax and pneumothorax with chest tube insertion was performed with fivefold cross validation testing the 
following models: Fine Tree, Medium Tree, Coarse Tree, Logistic Regression, Gaussian Naive Bayes, Kernel 
Naive Bayes, Linear SVM (Support Vector Machines), Quadratic SVM, Cubic SVM, Fine Gaussian SVM, Median 
Gaussian SVM, Coarse Gaussian SVM, Boosted Trees, Ensembled Trees, RUSBossted Trees.
A p value of < 0.05 was considered statistically significant. Statistical analysis was performed with Stata/MP 
Version 16 (StataCorp, College Station, TX, USA) and Matlab 2020 (The MathWorks, Natick, MA, USA).
Results
Among the 371 lung biopsies retrospectively analysed in this study, we identified 102 patients (27%) with an 
instant pneumothorax and 140 patients (38%) with overall pneumothorax. Thirty-five patients (9%) had a pneu-
mothorax with a size and symptoms requiring chest tube insertion while 231 patients (62%) did not develop a 
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pneumothorax at all. Table 1 summarises descriptive statistical results in the total study population and these 
four subgroups and effects of possible impact factors on the occurrence of lung biopsy-related pneumothorax.
Quantitatively determined pulmonary emphysema scores (%LAA-950) were significantly higher in patients 
who developed an instant pneumothorax (p < 0.0001), a pneumothorax overall (p = 0.001) and had a chest tube 
inserted (p = 0.006) compared to those without pneumothorax in the Mann–Whitney U-test. Figure 2 shows 
boxplots of %LAA-950 in these three groups of patients. Corresponding imaging examples of two patients with 
CT-guided lung biopsy are provided in Fig. 3.
To account for other factors with a possible impact on the pneumothorax rate following lung biopsy binominal 
logistic regression was used. Other factors analysed were length of lung parenchyma punctured, lesion diameter, 
lung lobe harbouring the lesion, biopsy needle size, puncture technique (coaxial or direct), patient positioning 
(prone, supine, lateral) and the interventionalist’s level of experience in terms of the number of lung biopsies 
performed before. In binominal logistic regression analysis of these parameters, only the pulmonary emphysema 
score and the lung parenchyma length punctured had a statistically significant positive impact on the likelihood 
of developing a pneumothorax following lung biopsy in all three subgroups, namely instant pneumothorax, 
overall pneumothorax and chest tube insertion. In these three subgroups, the pulmonary emphysema score 
yielded p < 0.001, p = 0.003 and p = 0.002 while the lung parenchyma length punctured yielded p = 0.035, p < 0.001 
and p < 0.001, respectively.
The results of binomial logistic regression analysis for instant pneumothorax are shown in Table 2a (p 
value < 0.0001), those for overall pneumothorax in Table 2b (p value < 0.0001) and those for chest tube insertion 
in Table 2c (p value = 0.0001).
In the logistic regression analysis of instant pneumothorax (Table 2a) and overall pneumothorax (Table 2b), 
lesion diameter showed a significant negative impact on the likelihood of developing instant pneumothorax 
(p = 0.007) and overall pneumothorax (p = 0.003), i.e., the larger the lesion the less likely a pneumothorax ensued. 
In addition, upper lobe localisation of the lesion had a significant negative impact on instant pneumothorax 
(p = 0.012), i.e., was less likely to result in a pneumothorax, and the direct puncture technique had a statistically 
significant positive impact on instant pneumothorax (p = 0.031), i.e., the direct puncture technique was more 
likely to result in instant pneumothorax.
Conversely, in the logistic regression analysis of chest tube insertion (Table 2c), lower lobe localisation of the 
lesion had a negative impact (p = 0.049).
The statistical significance of emphysema scores for the outcome parameters was confirmed with a Lasso 
regression model with control variables to be selected by lassos and tenfold cross-validation. This model yielded 
Table 1.  Descriptive statistics. For categorical variables the percentage (%) and for continuous variables 
the standard deviation (± SD) is given. %LAA-950 percentage of low-attenuation areas of less than − 950 
Hounsfield Units; UL upper lobe, LL lower lobe, ML middle lobe, G Gauge. *1p value of Chi-Square-Test for 





pneumothorax Chest tube required No pneumothorax
p value*1
Overall versus no 
pneumothorax
p value*1
Chest tube versus 
no chest tube
Number 371 102 (27%) 140 (38%) 35 (9%) 231 (62%) – –
Emphysema score 
(%LAA-950) 3.06 ± 6.31 5.06 ± 8.14 4.22 ± 7.26 5.81 ± 8.26 2.36 ± 5.56 0.001 * 0.006*
Lung parenchyma 
distance (mm) 20 ± 20 23 ± 22 26 ± 21 34 ± 29 16 ± 18 < 0.001* < 0.001*
Lesion diameter (mm) 32 ± 26 26 ± 16 26 ± 15 26 ± 13 36 ± 30 < 0.001* 0.150
Lung lobe
UL 191 (52%) 44 (43%) 75 (54%) 23 (66%) 116 (51%) 0.814 0.094
LL 158 (43%) 50 (49%) 57 (41%) 9 (26%) 101 (44%)
ML 20 (5%) 8 (8%) 8 (6%) 3 (9%) 12 (5%)
Biopsy needle size
16 G 6 (2%) 0 (0%) 0 (0%) 0 (0%) 6 (3%) 0.156 0.661
18 G 118 (32%) 30 (30%) 46 (33%) 12 (36%) 72 (31%)
20 G 244 (66%) 70 (70%) 92 (67%) 21 (64%) 152 (66%)
Puncture technique
Direct 107 (29%) 39 (38%) 46 (33%) 11 (31%) 61 (26%) 0.184 0.731
Co-axial 264 (71%) 63 (62%) 94 (67%) 24 (69%) 170 (74%)
Patient positioning
Prone 182 (49%) 57 (56%) 71 (51%) 12 (34%) 111 (48%) 0.452 0.120
Supine 171 (46%) 41 (40%) 65 (46%) 22 (63%) 106 (46%)
Lateral 17 (5%) 4 (4%) 4 (3%) 1 (3%) 13 (6%)
No of performed lung 
biopsies by interven-
tionalist
17 ± 13 15 ± 11 16 ± 12 17 ± 12 17 ± 13 0.222 0.340
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Figure 2.  Boxplot graphs of quantitatively determined emphysema scores (%LAA-950) of patients with lung 
biopsy-related instant pneumothorax, overall pneumothorax and chest tube insertion versus patients without 
pneumothorax.
Figure 3.  Images illustrating findings in two patients with CT-guided lung biopsy: patient A in row 1 with a 
high emphysema score and patient B in row 2 with a low emphysema score. Column 1 shows coronal plane 
CT images with automatic identification of voxels < − 950 HU depicted in blue and provides the resulting 
quantitative emphysema score (%LAA-950) generated with AW Server 3.2, Ext. 1.2, 2016 (https ://www.gehea 
lthca re.de/produ cts/advan ced-visua lizat ion/platf orms/aw-serve r), column 2 shows axial CT-fluoroscopy images 
with the biopsy needle in situ, and column 3 shows axial CT-fluoroscopy images of the same site after biopsy 
with and without pneumothorax.
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interval Z-value p value Sig
(a)
Emphysema score (%LAA-950) 1.075 1.034 1.117 3.660 < 0.001 **
Length of lung parenchyma punctured (mm) 1.014 1.001 1.027 2.100 0.035 *
Lesion diameter (mm) 0.977 0.961 0.994 − 2.710 0.007 **
Lung lobe
 UL 0.258 0.090 0.738 − 2.520 0.012 *
 LL 0.398 0.134 1.181 − 1.660 0.097
 ML 1 – – – –
Biopsy needle size
 16 G 1
 18 G 1.076 0.616 1.878 0.260 0.798
 20 G 1 – – – –
Puncture technique
 Direct 1.808 1.057 3.092 2.160 0.031 *
 Coaxial 1 – – – –
Patient positioning
 Prone 1.896 0.518 6.933 0.970 0.334
 Supine 1.309 0.348 4.929 0.400 0.690
 Lateral 1 – – – –
Interventionalist’s level of experience (number of performed lung biopsies) 0.978 0.958 1.000 − 1.980 0.047
Odds ratio
95% confidence 
interval Z-value p value Sig
(b)
Emphysema score (%LAA-950) 1.057 1.018 1.097 2.920 0.003 **
Length of lung parenchyma punctured (mm) 1.026 1.013 1.040 4.020 < 0.001 **
Lesion diameter (mm) 0.977 0.963 0.992 − 3.010 0.003 **
Lung lobe
 UL 0.583 0.211 1.610 − 1.040 0.298
 LL 0.527 0.182 1.525 − 1.180 0.237
 ML 1 – – – –
Biopsy needle size
 16 G 1
 18 G 1.491 0.894 2.488 1.530 0.126
 20 G 1 – – – –
Puncture technique
 Direct 1.378 0.826 2.298 1.230 0.219
 Coaxial 1 – – – –
Patient positioning
 Prone 2.473 0.693 8.831 1.390 0.163
 Supine 1.992 0.546 7.262 1.040 0.297
 Lateral 1 – – – –
Interventionalist’s level of experience (number of performed lung biopsies) 0.983 0.965 1.002 –1.790 0.074
Odds ratio
95% confidence 
interval Z-value p value Sig
(c)
Emphysema score (%LAA-950) 1.074 1.027 1.124 3.110 0.002 **
Length of lung parenchyma punctured (mm) 1.038 1.020 1.056 4.150  < 0.001 **
Lesion diameter (mm) 0.987 0.960 1.015 − 0.930 0.354
Lung lobe
 UL 0.419 0.104 1.689 − 1.220 0.221
 LL 0.202 0.041 0.993 − 1.970 0.049 *
 ML 1 – – – –
Biopsy needle size
 16 G 1
 18 G 1.340 0.590 3.044 0.700 0.485
 20 G 1 – – – –
Continued
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p = 0.001 for instant pneumothorax, p = 0.002 for overall pneumothorax and p = 0.001 for chest tube insertion 
(Table I of supplementary material). Additionally, measures of performance to predict instant pneumothorax, 
overall pneumothorax and pneumothorax with chest tube insertion was performed with fivefold cross validation 
and the resulting best models and their accuracy are given in Table 3.
Separate analysis of patients with %LAA-950 > 5% revealed an instant pneumothorax rate of 49% in this 
subgroup as opposed to 23% in patients with %LAA-950 ≤ 5% (Table II of supplementary material).
Separate analysis of the puncture technique with the Chi-square test confirmed the results of the logistic 
regression analysis with direct biopsy resulting in significantly more instant pneumothoraces (p = 0.014) than 
the coaxial puncture technique while no statistically significant difference was found between the two techniques 
with respect to overall pneumothorax (p = 0.184) and chest tube insertion (p = 0.731).
Discussion
In this retrospective analysis of 371 lung biopsies we found rates of pneumothorax (38%) and chest tube insertion 
(9%) similar to those reported in the  literature4,6.
On the other hand, our results clearly show that the quantitative pulmonary emphysema score (%LAA-
950) has a significant impact on the likelihood of developing a pneumothorax in general and a pneumothorax 
necessitating chest tube treatment with higher emphysema scores increasing the risk of being afflicted by a 
pneumothorax and requiring chest tube treatment. To our knowledge, only a few studies have so far investi-
gated quantitatively determined pulmonary emphysema as a predictor of pneumothorax following CT-guided 
lung biopsy. These studies included moderate numbers of patients and only one of them additionally evaluated 
chest tube  treatment14–16. Two of these studies found the quantitative emphysema score to be a predictor of 
 pneumothorax14,15 (n = 163 and n = 100) while one did  not16 (n = 97). Our analysis of n = 371 validates quantita-
tively determined pulmonary emphysema as a predictor of pneumothorax and is the first study to show that it is 
also a positive predictor of chest tube insertion for pneumothorax, which is contrary to the findings of the much 
smaller study of Lendeckel et al.15. The rather large study population we analysed and the quantitative method 
we used to determine pulmonary emphysema make our findings more robust than published data obtained with 
qualitative methods as outlined in the Introduction section and which are inconsistent with respect to the effect 
of pulmonary emphysema on the occurrence of lung biopsy-related  pneumothorax21.
In our study %LAA-950 was the strongest predictor of instant pneumothorax and the second strongest 
predictor of overall pneumothorax and chest tube insertion. The only other factor that also had an impact on 
all three output parameters analysed in this study, that is instant pneumothorax, overall pneumothorax and 
chest tube insertion, was the lung parenchyma length punctured. This finding is in accordance with previously 
published  data21,24.
Our analysis identified pulmonary lesion diameter as another predictor of instant and overall pneumothorax 
after lung biopsy with smaller lesions increasing the risk, another result consistent with earlier  findings17.
Odds ratio
95% confidence 
interval Z-value p value Sig
Puncture technique
 Direct 1.326 0.558 3.153 0.640 0.523
 Coaxial 1 – – – –
Patient positioning
 Prone 0.811 0.086 7.661 − 0.180 0.855
 Supine 1.340 0.142 12.668 0.260 0.798
 Lateral 1 – – – –
Interventionalist’s level of experience (number of performed lung biopsies) 0.999 0.969 1.031 − 0.040 0.969
Table 2.  (a) Binomial logistic regression analysis of factors predicting lung biopsy-related instant 
pneumothorax. N = 358. p value of the model < 0.0001. (b) Binomial logistic regression analysis of factors 
predicting lung biopsy-related overall pneumothorax. N = 358. p value of the model < 0.0001. (c) Binomial 
logistic regression analysis of factors predicting pneumothorax with chest tube insertion after lung biopsy. 
N = 357. p value of the model = 0.0001. %LAA-950 percentage of low-attenuation areas of less than − 950 
Hounsfield Units; UL upper lobe, LL lower lobe, ML middle lobe, G Gauge—omitted because of collinearity; 
**p < 0.01; *p < 0.05.
Table 3.  SVM: support vector machines; AUC: area under the curve.
Instant pneumothorax Overall pneumothorax Pneumothorax with chest tube insertion
Model Linear SVM Coarse Gaussian SVM Gaussian Naive Bayes
AUC 0.70 0.69 0.73
Accuracy 72.8% 62.3% 86.2%
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We also found a significantly lower pneumothorax rate when the coaxial puncture technique was used, pro-
viding further support for preferring this technique over the direct puncture  technique18.
Interestingly, our results do not show an impact of the interventionalist’s experience on the likelihood of 
lung biopsy resulting in pneumothorax, which is contrary to the results reported by Yeow et al.17 and Winokur 
et al.20. Our result might be explained by the fact that the risk factors that can be influenced by the interventionist 
boil down to correct puncture pathway planning as specified in the CT fluoroscopy and interventional workflow 
subsection of Materials and Methods and that it is our policy that the interventionalist generally discusses the 
planned pathway with an experienced colleague before the intervention. All biopsies investigated in this study 
were performed by radiologists who started their interventional career during the observed time period, gener-
ally radiologists in their 5th year of residency to obtain board certification. This setting allowed us to estimate 
the interventionalist’s experience based on the number of lung biopsies performed before the one included in 
the analysis.
In a separate analysis of patients with %LAA-950 greater than 5%, we found an instant pneumothorax rate 
of 49% versus 23% in those with scores of 5% or less. This nicely illustrates the key message that pulmonary 
emphysema is a risk factor for the occurrence of pneumothorax, but also clearly underlines that we will encounter 
pneumothorax also in patients with little to no emphysema. Given that pneumothorax is a treatable condition, 
we therefore think that lung biopsies should not be withheld from patients with pulmonary emphysema as long 
as there is a clear clinical indication.
Our study has several limitations that need to be discussed.
Automatic segmentation of the lung and emphysema scoring with the density mask technique as used in this 
retrospective analysis is currently the only method to objectively quantify the extent of emphysematous lung 
destruction. While the use of this objective and reproducible method is an asset of our study, it has to be pointed 
out that the emphysema score does not take into account other aspects of emphysema-associated lung destruc-
tion such as peribronchial thickening or nonemphysematous lung tissue impairment, which may also affect 
the likelihood of pneumothorax development during lung biopsy. Therefore, visual scoring, while being more 
time-consuming and subjective, might ultimately be a better predictor as found in a study predicting mortality 
in patients with chronic obstructive pulmonary disease (COPD)25.
We did not use the same technique for pulmonary tissue sampling in all patients included in our analysis. 
In the majority of cases, we used the recommended combination of a coaxial needle with a cutting needle and 
obtained two tissue  samples18,26–28; however, in some cases we used a larger cutting needle alone and obtained 
only one tissue  sample29. Moreover, the needle size varied slightly. The technique and needle size were retrieved 
from the records and included in the logistic regression and lasso regression analysis. Overall, however, we must 
be aware that documentation may be incomplete, e.g., with respect to the number of samples taken, and some 
variations are therefore possibly not accurately captured in this retrospective analysis.
Puncture-site-down positioning of the patient immediately after the intervention was reported to reduce 
the incidence of biopsy-related pneumothorax requiring chest tube insertion while the incidence of less severe 
pneumothorax was found to be  unaffected30,31. Puncture-site-down positioning after lung biopsy is promoted 
in our department. However, we cannot verify how rigorously it was adhered to by interventionalists. As all 
interventionalists included in this study started their interventional career during the observed time period and 
acquired their skills from the physician previously working in the position it is likely, though, that they adopted 
established procedures and measures.
Furthermore, some authors promote a lateral position of the patient with the lung to be punctured pointing 
downwards during the biopsy  procedure32,33. This is a method not generally endorsed at our institution because 
we think that the position that allows the best access to the pulmonary target lesion and at the same time is 
most comfortable for the patient, thus ensuring the best compliance and minimising movement, outweigh the 
potential benefits from a lateral position with the punctured lung pointing downwards. In some cases, the posi-
tion ensuring the best access to the lesion and the lateral position with the punctured lung pointing downwards 
might have coincided, resulting in a slightly lower likelihood of pneumothorax. However, these would have been 
only very few cases and the impact, if at all present, would not have been great.
Lastly, there is some leeway when deciding on the need to insert a chest tube, a decision which is primarily 
based on the severity of pneumothorax and the patient’s symptoms. In some instances, therefore, another physi-
cian might have decided differently. This might render the outcome parameter of chest tube insertion a bit more 
arbitrary than pneumothorax development as such.
In conclusion, quantitatively determined pulmonary emphysema extent is a positive predictor of the likeli-
hood of pneumothorax development in CT-guided lung biopsy and the need for chest tube insertion.
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